Curis (NASDAQ:CRIS) focuses on innovating and developing new treatments in the fight against cancer. With a passion for leveraging the latest in molecular and cancer biology to unlock new therapeutic pathways, Curis is dedicated to the discovery and development of groundbreaking drug candidates. The company's projects span various stages of clinical trials, aiming to address some of the most challenging oncological targets. Central to their mission is the objective to provide novel, effective therapies to improve the lives of patients struggling with cancer. By pushing the boundaries of current treatment paradigms, Curis endeavors to make significant contributions to oncology and patient care.